Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.

Santiago Barrio,T. D. Shanafelt,Juhi Ojha,Kari G. Chaffee,Charla Secreto,Klaus Martin Kortüm,S. Pathangey,D L Van Dyke,Susan L Slager,Rafael Fonseca,Neil Elliot Kay,Esteban Braggio

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.

2017

Santiago Barrio
T. D. Shanafelt
Juhi Ojha
Kari G. Chaffee
Charla Secreto
Klaus Martin Kortüm
S. Pathangey
D L Van Dyke
Susan L Slager
Rafael Fonseca
Neil Elliot Kay
Esteban Braggio

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome

Keywords:

Genetics
Cancer research
Biology
Pathology
early detection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations